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from studies if diagnostic scans revealed pathological long
bone fractures or cord compression. Beneﬁts of exercise
included increased lower body strength, perceived quality of
life, and adherence to training regimens when supervised by
an exercise physiologist or physical therapist. Select studies
also revealed a positive inﬂuence on body composition and
systolic blood pressure.
Discussions & Implications: Research supports that pa-
tients undergoing autologous hematopoietic stem cell
transplant for multiple myeloma beneﬁt from exercise.
However, there is room to explore the effect exercise has in
decreasing secondary complications that can occur following
HSCT. We plan on presenting these ﬁndings to leadership to
pursue development of an exercise program for our patients
with Multiple Myeloma pre-, during, and post-autologous
HSCT.566
Subcutaneous Ports for Outpatient Transplant Patients to
Reduce the Risk of Central Line Associated Blood Stream
Infections
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Cleveland Clinic performed 66 outpatient reduced intensity
transplants from 2009-2014. Of those patients 45 (68%) were
admittedwithin the ﬁrst 100 days of their transplant. 34 out of
66 (52%) of outpatient transplant patients from 2009-2014
were diagnosedwith a catheter related blood stream infection
and 18 (53%) were within the ﬁrst 100 days. Traditionally,
these patients have a triple lumenHickman (TLH) placed prior
to starting their preparative regimen that stays in place for the
duration of their treatment (Schiffer, 2013). Due to the
chemotherapy, immune suppressive medications, and central
lines, these patients are at higher risk of infection. Patients are
taught to maintain this line at home, which consists of
ﬂushing each lumen daily and changing the bandage and caps
weekly. If infections occur, patients are admitted to the hos-
pital for evaluation and treatment. Infections can increase this
patient population’s morbidity and mortality (Viscoli et al,
2005). Infections cost over $45,000 per case for the hospital
and patient (Schiffer, 2013). Increasing patient outcomes and
decreasing costs are goals of transplant programs, which may
be achieved by decreasing infection rates.
Methods, Intervention, & Analysis: A review of literature
indicated that subcutaneous ports instead of TLH have the
potential to decrease risk of infection though the body of
current literature does not include transplant patients. The
articles reviewed focused on oncology patients, pediatric and
adult, receiving chemotherapy.
Findings & Interpretation: The information analyzed in-
dicates strong evidence to support subcutaneous port use
instead of TLH in transplant patients but since no infor-
mation speciﬁcally looks at transplant patients, further
investigation is needed. Patients prefer ports due to low self-
maintenance which could decrease infections due to patient
adherence to line care. Some patients have ports in place
from prior therapy and therefore would not need a second
procedure to place TLH. Due to the reduced intensity of the
chemotherapy used in outpatient transplants, it is reason-
able to apply this change.Discussion & Implications: As of July 31, 2014, Cleveland
Clinic will use ports instead of TLH for the next 10 patients
receiving an outpatient allogeneic transplant. These patients
will be tracked for line infections and admission rates within
100 days after transplant.567
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Indications for stem cell transplantation (SCT) in the pediatric
population are increasing, and patients are expected to live
long and productive lives. However, they do require lifelong
follow up, dictated by the initial diagnosis and late toxicities.
Like most pediatric centers, patients over 21 years old can no
longer be followed by our pediatric team and need to be
transferred to an adult facility. At our institution, we are facing
the challenge of a lack of available resources to transfer all of
our patients to an adult transplant facility. In this situation,
how can we best provide patients with a proper and safe
follow-up when the adult transplant center cannot accept the
entire patient cohort?
Methods, Intervention, & Analysis: In order to achieve this
goal, we have developed a standardized protocol to direct
our patients toward the most appropriate facility. Referral to
the adult transplant team is restricted to those patients
presenting with GVHD, hematologic toxicity or more than
two organs’ involvement. All of our other patients, which
represent the vast majority, will be referred to their family
physician with speciﬁc guidelines. However, most of them
don’t have a family physician as the follow up of SCT patients
may seem complex.
Findings & Interpretation: First, our protocol will help
guide and support our patients in identifying a family
physician, which can take up to two years. Once a referring
doctor is found, the transplant physician and the nurse
navigator will prepare a ﬁle containing the patient medical
summary and guidelines detailing the recommended follow
up and possible long term sequelae. Also, our team remains
available to answer questions. Finally, we encourage family
physicians to send us periodical summary charts.
Discussion & Implications: Information about the recom-
mended follow up and good life habits are previously given
to patients to promote their autonomy and facilitate a
smooth transition. This procedure is an important part of our
teenagers transplant clinic that was just implemented. This
procedure started about a year ago, and so far, it seems to be
a positive experience for everyone involved.568
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
The Blood andMarrow Transplant (BMT) patient population is
highly susceptible to acquiring a Clostridium difﬁcile (c. diff)
infection. The prolonged neutropenic status causes c. diff in-
fections to be more severe and longer lasting in this patient
population (Rev Inst Med Trop Sao Paulo. 2014 Jul;56(4):325-
31). On average, the cost of a Hospital Acquired Infection (HAI)
of c. diff is $11,285 per incident (JAMA Intern Med 2013;
173(22)2039-2046). The current practice of sanitizing with
bleach wipes with all patients has minimal effect on c. diff
rates (Clin Infect Dis. (2000) 31 (4): 995-1000).
Methods, Intervention, & Analysis: Starting November
2013, the University of Minnesota Health Adult BMT unit
experienced an increased prevalence of c. diff in the inpatient
population. As a result, the unit switched their sanitizing
practices to universally sanitizing with a hypochlorite solu-
tion. Previously, only rooms of patients testing positive for a
c. diff infection were sanitized with a hypochlorite solution.
This switch did not result in a signiﬁcant drop in c. diff rates
per one thousand patient days. In February, a silver based
solution (Steriplex SD & Steriplex 360) was adopted unit
wide to replace the hypochlorite solution. The use of all other
sanitizing products was discontinued. C. diff rates were
measured by patient lab reports.
Findings & Interpretation: Findings demonstrated that the
switch to silver basedwipes from bleach based wipes reduced
c. diff infection rates among the BMT population, as demon-
strated by the drop in the rate of active c. diff from 5.5/1000
patient days to 0/1000 patient days. The current hospital
practice to reduce the transmission of active c. diff infection is
the use of bleach based wipes. Implications of the study
include: ongoing advocacy of improved infection prevention
measures in the care of BMT patients, further conversations
with the infection control department about c. diff infection
control practices in the BMT population, as well as consider-
ation for switching disinfection products hospital wide.
Discussion & Implications: Based on these ﬁndings, we
have switched solely to sanitizing with the silver-based so-
lution. We recommend the use of this solution to the
outpatient BMT clinic. This practice would be beneﬁcial in
protecting all patient populations including those with he-
matological/oncological conditions.569
Pre-Transplant Caregiver Education for Out-Patient
Multiple Myeloma Hematopoietic Transplant Admission
in New Day Hospital: Caregiver Role and Contract in
Outpatient Transplant Patient Care
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Hematopoietic transplantation is a complex procedure.
Excellent education and discussionwith patients and family is
imperative because of increasingly complicated clinical and
psychosocial management of their care. In the early steps of
pre-transplant preparation, before admission, it is important
to initiate discussion with the patient and family about
discharge teaching. This was important when moving autol-
ogous transplant in outpatient day hospital.To discuss process of patient/caregiver evaluation and
caregiver support during patient day hospital visits: 1) the
implementation of Pre transplant Caregiver education; 2)
identify speciﬁc content areas for pre-transplant teaching; 3)
additional methods of teaching involving both patient and
caregiver.
Methods, Intervention, & Analysis: A group was formed to
develop Day Hospital HCT Discharge Teaching to: 1)
improve patient/family caregiver education about outpa-
tient HCT multiple myeloma in the day hospital; 2) create
content and develop methods for patient & caregiver edu-
cation in preparation for admission to the Day Hospital and
3) develop and adminster satisfaction survey of new OPD
transplant process.
Findings & Interpretation: A task force of staff nurses, nurse
practitioner, nurse educators, nursing leaders, case managers,
and clinical social workerwas assembled to develop caregiver
education which included the caregiver attending a group
class facilitated by a nurse coordinator; caregiver contract;
and complete symptom management forms. In addition,
nurse coordinators and day hospital staff review speciﬁc
content for HCT patient care, common medications and side
effects, expected transplant related symptoms, discharge is-
sues which include VAD care, infection precautions, dietary
restrictions, home preparation, clinic routine, and long term
survivorship topics with the caregiver. With the pre-trans-
plant education, patient and caregiver satisfactionwas high at
day of transplant (caregiver 90.3%, patient 91.8%) and at day of
discharge (patient only 90%); with these efforts, it achieved a
decrease in the HCT number of length of stay days from 21
days to 14 days. Ninety two percent of patients (n¼12)
received their stem cells in an outpatient setting.
Discussion & Implications: There was improved coopera-
tion between physician/mid-level/nursing teams resulting in
timely and efﬁcient care and cooperation between outpa-
tient and inpatient; patient obtained prescribed medication
100% and patient expressed quality of life is better main-
tained. The institutional commitment to the program has
promoted seamless care.570
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Advances in the design of CVCs has led to a variety of features
that increase the functionality of CVCs used in the care of BMT
patients. Examples of these features include: power injection
of contrast media, central venous pressure (CVP) monitoring,
apheresis procedures including stem cell collection, plasma
exchange and extracorporeal photopheresis. However,
matching the right CVC with the individual treatment re-
quirements for BMT patients can be a challenge. For example,
CVC’s composed of polyurethane are not recommended for
infusion containing high concentrations of alcohol (e.g., un-
diluted etoposide). At our institution, an opportunity for
improvement was identiﬁed due to an increase in occurrences
of inappropriate CVC selection. The decision to develop a
nurse-initiated protocol was based on the knowledge of
infusion therapy.
